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The innate recognition of fungal pathogens is a crucial first step in the induction of protective antifungal
immunity. Complement is thought to be one key component in this process, facilitating fungal recognition and
inducing early inflammation. However, the roles of the individual complement components have not been
examined extensively. Here we have used mice lacking C3 to examine its role in immunity to opportunistic
fungal pathogens and show that this complement component is essential for resistance to infections with
Candida albicans and Candida glabrata. We demonstrate that the absence of C3 impairs fungal clearance but
does not affect inflammatory responses. We also show that the presence of C3 contributes to mortality in mice
challenged with very high doses of Saccharomyces cerevisiae, although these effects were found to be mouse
strain dependent.
Over the last few decades, modern medical practice and
acquired immunodeficiencies have contributed to a substantial
increase in the incidence of infections with normally commen-
sal or nonpathogenic fungi (22), prompting a renewed interest
in expanding our understanding of the mechanisms underlying
protective host immunity. Identification and characterization
of the receptors involved in the innate recognition of these
organisms are of particular importance, as these “pattern rec-
ognition receptors” (14) not only are responsible for mediating
the recognition and uptake of fungi by phagocytes but also
initiate and direct the resultant immune response (17). While
numerous nonopsonic pattern recognition receptors for fungi
have been well characterized, including several members of the
C-type lectin and Toll-like receptor families (for recent re-
views, see references 20, 21, and 32), less is known about the
opsonic mechanisms of fungal recognition, such as those me-
diated by complement, despite the essential role of these sys-
tems in antifungal immunity (24).
The complement system consists of more than 30 serum and
cellular surface proteins and is activated through three main
routes: the classical, alternative, and lectin pathways. Trigger-
ing of these three pathways initiates enzymatic cascades which
converge on the third complement component, C3, whose ac-
tivation leads ultimately to microbial opsonization, the release
of chemotactic factors, including C3a and C5a, and the gener-
ation of a membrane attack complex (MAC) (18). Activation
of the classical pathway occurs primarily following the binding
of C1q to antibody-antigen complexes, and although involved
in the adaptive arm of the immune system, this pathway is also
triggered by natural antibodies, thereby contributing to the
innate recognition of fungi (16). Initiation of the alternative
pathway occurs through the spontaneous activation of C3 on
microbial surfaces, and the lectin pathway is initiated by the
binding of the mannose-binding lectin to carbohydrates on
microbial surfaces (24).
All three of these pathways are induced by opportunistic
fungal pathogens, including Candida albicans (13, 15, 24), al-
though the alternative pathway may be the most critical (7, 15).
The protective role of complement in immunity to these patho-
gens has largely been determined in mice treated with cobra
venom factor (CVF), which depletes serum complement by
forming a potent C3 convertase, or in C5-deficient mouse
strains, such as A/J or DBA2, where fungal opsonization re-
mains intact but the animals lack the ability to generate C5a or
the MAC (6, 7, 9, 10, 19). Why C5-deficient mice are suscep-
tible is still unclear, but is likely to be due to aberrant inflam-
matory responses, as the MAC has little effect on the viability
of fungal pathogens (15, 19). Although the roles of each of the
pathways of complement activation have been relatively poorly
examined, recent studies have started to address this issue,
looking at the role of factor B, C2, C1q and mannose-binding
lectin in the control of systemic candidiasis (11).
C3 is a central component in all of the complement path-
ways, as described above, but it has not been studied in isola-
tion with respect to fungal infection. Studying the role of this
complement component in isolation is particularly relevant,
given the alternative route of C5 activation by thrombin, which
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can substitute for C3-dependent C5 convertase activity (12,
30). Therefore, we undertook to specifically examine the role
of C3 in the control of opportunistic fungal infections using
C3-sufficient and C3-deficient mice.
MATERIALS AND METHODS
Mice. Seven- to 14-week-old female C57BL/6, C57BL/6 C3/ (backcrossed
for 10 generations) (29), DBA/2, and BALB/c mice were obtained from the
specific-pathogen-free facility of the University of Cape Town. All animal ex-
perimentation was repeated at least once, unless otherwise indicated, and con-
formed to institutional guidelines for animal care and welfare. All experiments
utilized at least six mice per group.
Systemic fungal models. C. albicans SC5314 (27) in Sabouraud broth at 30°C
or Candida glabrata (ATCC 2001) and Saccharomyces cerevisiae BY4741 (3), in
yeast-peptone-dextrose broth at 37°C were cultured for 24 h. Yeasts were washed
twice in phosphate-buffered saline (PBS) and intravenously (i.v.) inoculated in
100 l into anesthetized animals, at the doses described in the text. Mice were
sacrificed at various time points, as described, or when judged moribund, which
included 20% loss of body weight. All remaining mice were sacrificed at 21 days,
which was considered to be the end of the experiment.
Peritoneal candidiasis. The in vivo peritoneal inflammatory response model
was performed essentially as described previously (27). In brief, mice were
inoculated intraperitoneally (i.p.) with C. albicans (SC5314; 1  106 or 1  107
CFU) and were sacrificed after 4 h or 4 days. The peritoneal inflammatory
infiltrate was collected by lavage with 2 ml ice-cold 5 mM EDTA in PBS.
Cytokines and cellular populations in the inflammatory isolates were analyzed as
described below.
To demonstrate the presence of complement in the peritoneal cavity, lavage
fluid was harvested following the injection of 2 ml of Hanks balanced salt
solution (HBSS) into the peritoneum. This fluid was then used to opsonize C.
albicans yeast for 30 min at 37°C with shaking. Freshly collected serum (used at
40% in HBSS) was used as a control. The yeast particles were then washed with
HBSS, and the deposition of C3 was determined by flow cytometry, as described
below.
Flow cytometery and antibodies. Fluorescence-activated cell sorting (FACS)
was performed according to conventional protocols at 4°C in the presence of 2
mM NaN3, as previously described (26). Surface expression of selected markers
was detected using fluorescein isothiocyanate (FITC)-conjugated anti-C3, biotin-
conjugated anti-Gr-1, FITC-conjugated anti-7/4, FITC-conjugated anti-CD11b
(clone 5C6) (23), anti-F4/80, and irrelevant rat immunoglobulin G2b biotin- and
/FITC-unconjugated isotype controls (all produced in house). Phycoerythrin-
conjugated donkey anti-rat immunoglobulin G (Jackson) was used as a second-
ary antibody to detect unlabeled primary antibodies. Biotinylated antibodies
were detected using streptavidin-allophycocyanin (BD, Pharmingen). Cells were
fixed with 1% formaldehyde in PBS before analysis. All FACS analyses were
performed using a BD Biosciences FACSCalibur and CellQuest software.
Cytokine and MPO analysis. Growth factor, chemokine, and cytokine con-
centrations were measured in kidney homogenates, serum, or peritoneal lavage
fluids using the Bio-Plex protein array system (Bio-Rad) as directed by the
manufacturer. Kidney homogenates were prepared by homogenizing the organs
in PBS containing 0.05% Triton X-100 and protease inhibitors (Complete
EDTA-free protease inhibitor cocktail; Roche). Myeloperoxidase (MPO) activ-
ity was determined by homogenizing isolated kidneys in hexadecyl trimethyl
ammonium bromide buffer. The homogenate was sonicated for 20 pulses at an
output of 9 W followed by centrifugation for 10 min at 10,000  g to remove any
remaining fragments of tissue. o-Dianisidine was added to a sample of the
homogenate, and the mixture was incubated at 35°C for 10 min. The amount of
MPO activity was determined by measuring the absorbance following the addi-
tion of 0.005% H2O2 at 460 nm.
Statistics. Student’s t test was used for analysis of two groups, with paired
analysis when appropriate, while the Mann-Whitney test was used for the anal-
ysis of nonparametrically distributed data. Survival data were analyzed with the
log rank test. Results were considered statistically significant with P values
of 0.05.
RESULTS
Mice deficient in C3 are susceptible to infection with C.
albicans. To explore the role of C3 in the control of fungal
infection, we systemically infected C3-sufficient and -deficient
mice with a low (1  104 CFU), intermediate (2  104 CFU),
or high (1  105 CFU) dose of C. albicans SC5314 and mon-
itored survival of the animals over time (Fig. 1). In contrast to
wild-type mice, which were fully resistant to infection with the
low dose of C. albicans, more than 55% of the C3/ mice died
during the course of this experiment. All of the C3/ mice
rapidly succumbed to the infection with the higher inoculums
of C. albicans, although these doses also induced some mor-
tality in the wild-type animals.
To characterize the susceptibility of the C3-deficient mice in
more detail, we examined animals at day 3 following systemic
infection with a low dose (1 104 CFU) of C. albicans (Fig. 2).
This early time point was chosen to allow immunological dif-
ferences to be determined, prior to the mice succumbing to
infection (Fig. 1). We first examined the kidney, which is the
target organ for C. albicans in mice (1), and found significantly
higher fungal burdens in C3/ animals (28,150  7,657
CFU/g) compared to the wild-type controls (3,611  1,850
CFU/g) (Fig. 2A). These higher fungal burdens correlated with
significantly elevated levels of a variety of proinflammatory
cytokines and chemokines (Fig. 2B), and we also observed
significantly elevated levels of interleukin-1 (IL-1), granulo-
cyte colony-stimulating factore (G-CSF), Keratinocyte-derived
chemokine (KC), and IL-17 in the peripheral blood of the
C3/ mice, although no Candida was detectable in the blood
at this time point (Fig. 2C) (data not shown). We also observed
increased leukocyte accumulation (predominantly neutrophils
and macrophages) in the kidneys of the C3/ animals, which
FIG. 1. C3 deficiency increases susceptibility to infection with C. albicans. C57BL/6 wild-type (F) and C3-deficient (E) mice were infected with
a low (1  104 CFU), intermediate (2  104 CFU), or high (1  105 CFU) dose of C. albicans i.v. and were monitored for survival over 21 days,
as described in Materials and Methods. The numbers of mice infected in each experiment are indicated in the figure and are representative of at
least two independent experiments (1  104 and 2  104 CFU) or a single experiment (1  105 CFU). *, P  0.05.
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was quantified by measuring MPO activity (Fig. 2D). However
there was no difference in the gross pathologies of kidneys
from infected wild-type and C3/ mice at this time point (Fig.
2E). Overall, these results demonstrate that C3 is essentially
required for resistance to infection with C. albicans.
The loss of C3 does not affect early inflammatory responses
but delays fungal clearance. The susceptibility of the C3-defi-
cient mice to systemic infection with C. albicans is likely to be
due to defects in fungal clearance and/or defective inflamma-
tory responses. We first explored the latter possibility and
characterized inflammatory responses following peritoneal
challenge with C. albicans, using a model we had previously
used to characterize inflammatory defects in Dectin-1/ mice
(27). Although not truly representative of systemic infection,
this model allows for the quantitation of inflammatory re-
sponses and was appropriate for this study as we could show
that complement was present in the peritoneal cavity (Fig. 3A).
For these experiments, we infected mice i.p. with 1  106 CFU
of C. albicans, and inflammatory responses were monitored at
early (4 h) and late (4 days) time points (Fig. 3B to E). By 4 h,
there was no defect in the inflammatory response of the C3-
deficient animals, both in terms of cellular recruitment (total
cells, neutrophils, and monocytes) (Fig. 3B and C) as well as in
the production of peritoneal cytokines (Fig. 3D). In fact, there
were slightly higher levels of KC, eotaxin, and IL-1 in the
C3/ mice, although this is unlikely to be biologically rele-
vant. Similar findings were also obtained at 4 h following i.p.
infection with a high dose (1  107 CFU) of C. albicans (Fig.
3E). These data therefore suggest that early inflammatory re-
sponses are not significantly affected by C3 deficiency.
By day 4, following i.p. infection with a low dose of C.
albicans, we did observe a slight, but significant, reduction in
the total numbers of cells recruited to the peritoneal cavity in
the C3/ animals, although the relative percentage of the
various cellular subpopulations, such as macrophages, re-
mained unchanged (Fig. 4A and B) (data not shown). Further-
more, we did not detect differences in the level of any cytokine
between wild-type and C3/ animals (Fig. 4C). We were
unable to explore the effect of C3 deficiency with higher fungal
doses on day 4, as the C3/ mice succumbed to infection by
this time point (data not shown). These results therefore sug-
gest that C3 deficiency does not significantly affect inflamma-
tory responses to C. albicans.
We next examined fungal clearance following systemic in-
fection in wild-type and C3-deficient mice. For these experi-
ments, mice were infected i.v. with a low dose (1  104 CFU)
of C. albicans and the clearance of this pathogen from various
organs was monitored over time (24, 48, and 72 h) (Fig. 5). By
24 h, delayed clearance was evident, with higher fungal bur-
dens detected in the organs of most of the C3/ mice. In
contrast, the organs of many of the wild-type animals had
undetectable fungal loads, except for the spleen and kidney. By
48 h, C. albicans could still be detected in all of the organs of
some C3/ animals, although only the fungal burdens in the
spleen and kidney were significantly different from those of the
wild-type animals. By 72 h, although not significantly different,
there was evidence of fungal outgrowth in the organs of C3/
animals, including the lung and brain, whereas the wild-type
animals had largely contained the infection by this time point
and appeared to have started clearing the fungus from their
kidneys and spleen. Thus, these data suggest that the enhanced
susceptibility of C3-deficient animals to C. albicans stems from
their inability to clear the pathogen.
FIG. 2. C3 deficiency correlates with increased inflammation and fungal burdens. On day 3 following i.v. infection with a low dose (1  104
CFU) of C. albicans, higher fungal burdens (A) and exacerbated inflammatory cytokines (B) were observed in the kidneys of C3-deficent mice (E)
compared to wild-type (wt) animals (F). The values are as follows: RANTES, 145  16 versus 39  4 pg/ml; G-CSF, 1,054  228 versus 290 
120 pg/ml; KC, 326 32 versus 147 57 pg/ml; IL-1 (IL-1b), 2,936 492 versus 1,184 290 pg/ml; macrophage inhibitory protein 1 (MIP-1a),
265  51 versus 57  23 pg/ml; IL-1 (IL-1a), 127  24 versus 44  16 pg/ml; macrophage inhibitory protein 1 (MIP-1b), 27  5 versus 9 
2 pg/ml; and IL-17, 3.6 0.6 versus 1.3 0.2 pg/ml. Higher levels of selected proinflammatory cytokines were also detected in the peripheral blood
of these animals (C). The values are as follows: G-CSF, 414  176 versus 2  1 pg/ml; KC, 199  34 versus 59  12 pg/ml; IL-1, 23  2 versus
9  2 pg/ml; and IL-17, 141  9 versus 5  3 pg/ml. Although there was a significant increase in polymorphonuclear leukocyte accumulation in
the kidneys of the C3/ animals, as quantified by histology (not shown) and measurement of MPO activity (D), there was no difference in the
gross pathologies of these tissues, as determined by hematoxylin and eosin staining (E). *, P  0.05 (n 	 7 animals per group per experiment).
The data shown in panel A are pooled from two independent experiments. Bars indicate mean values of the data.
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Mice deficient in C3 are susceptible to systemic infection
with C. glabrata. We also examined the role of C3 in the control
of C. glabrata, another organism which has been associated
with infections in immunocompromised hosts. For these ex-
periments, wild-type and C3-deficient mice were infected i.v.
with 7  107 CFU and survival was monitored over time. In
contrast to the wild-type mice, which were fully resistant to
infection with C. glabrata, as expected (1), nearly all of the
C3/ mice had succumbed to infection with this organism
(Fig. 6). These data therefore demonstrate that C3 is essen-
tially required for resistance to infection with C. glabrata.
C3 deficiency protects mice against high-dose infection with
S. cerevisiae. Although not normally considered a pathogen,
isolates of S. cerevisiae have been linked to disease in immu-
nocompromised individuals, an effect which may be related to
changes in the cell wall of the organism (31). Furthermore,
clinical strains of S. cerevisiae have been shown to cause lethal
infections in C5-deficient mice (4), and we therefore explored
the possibility that C3 would be important for resistance to
infection with a nonpathogenic strain of S. cerevisiae. For these
experiments, we infected wild-type and C3/ mice i.v. with a
high dose (1  108 CFU) of a laboratory strain of S. cerevisiae
and monitored survival over time (Fig. 7). Surprisingly, more
than 80% of the C57BL/6 wild-type mice died within 24 h
following i.v. administration of this organism, whereas the
C3/ animals all survived the infection. We also examined
high-dose infection in DBA/2 mice, which are deficient in the
C5 component of complement, and observed that these ani-
mals were also fully resistant to high-dose infection with S.
cerevisiae (Fig. 7). However, we found that infection with this
dose of S. cerevisiae induced only 14% mortality in wild-type
BALB/c mice, suggesting that the level of this response is
dependent on the mouse strain background (Fig. 7). Overall,
these results demonstrate that C3 can contribute to mortality
upon infection with high doses of S. cerevisae.
DISCUSSION
Complement plays an important role in immunity to many
pathogens: by direct killing through the formation of a MAC,
by acting as opsonins and facilitating microbial uptake, and by
inducing inflammation. Fungi, in particular, have been known
FIG. 3. C3 deficiency does not affect early inflammatory responses to C. albicans. C3/ and wild-type mice were infected i.p. with 1 106 CFU
of C. albicans, and inflammatory responses were measured at 4 h. (A) Incubation of isolated peritoneal fluid (gray histogram) or serum (unfilled
histogram) with Candida albicans leads to C3 deposition on the fungal surface. The dark-gray portion of the histogram indicates unstained particles
(secondary-only control). (B) Representative flow cytometric profiles showing the gates used (25) to identify recruited neutrophil (NØ) and
monocyte/macrophage (Mo) populations. C3 deficiency does not affect cellular recruitment (wild type, 5.71  106  4.31  105 total cells/ml)
(C) or reduce inflammatory cytokine production (D) following i.p. administration of C. albicans. The values for the wild type are as follows:
RANTES, 10.5 2.0 pg/ml; G-CSF, 2,218 434 pg/ml; granulocyte-macrophage CSF (GM-CSF), 29.7 3.7 pg/ml; macrophage inhibitory protein
1 (MIP-1a), 313  36 pg/ml; tumor necrosis factor (TNF), 211  37 pg/ml; IL-6, 6,161  1,169 pg/ml; monocyte chemoattractant protein 1
(MCP-1), 5,062  941 pg/ml; IL-1 (IL-1a), 28.8  3.6 pg/ml; IL-10, 43.7  10.0 pg/ml; and macrophage inhibitory protein 1 (MIP-1b), 167 
12 pg/ml. Values for the wild type versus C3/ are as follows: eotaxin, 3,557  538 versus 7,368  811 pg/ml; KC, 539  142 versus 1,124  180
pg/ml; and IL-1 (IL-1b), 77  14 versus 120  11 pg/ml. (E) C3 deficiency also has no effect on inflammation following i.p. infections with higher
doses (1  107) CFU of C. albicans (wild type, 6.02  106  9.32  105 total cells/ml). *, P  0.05 (n 	 6 animals per group per experiment).
The data shown in panel C are pooled from three independent experiments. Bars indicate mean values of the data.
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to trigger complement activation since the 1900s and have
been used to help define the activation pathways (2). Although
fungi appear to be resistant to complement-mediated killing,
presumably because of their thick cell walls, the opsonic and
inflammatory components of complement are thought to play
a central role in antifungal immunity (15, 28). The role of
complement has, however, largely been determined through
the use of CVF, although C5-deficient mice have also been
examined. Given the thrombin-dependent, C3-independent,
pathway of C5 activation (12, 30), we undertook to examine the
role of C3 in immunity to several opportunistic fungal patho-
gens using C3-sufficient and C3-deficient mice.
C. albicans can trigger all three pathways of complement
activation, leading to the rapid deposition of C3 on the surface
of this organism and facilitating its uptake by phagocytes (15).
Animals treated with CVF, or having deficiency in C5, are
more susceptible to both systemic and cutaneous candidiasis
(15), and here we show that C3 is also an essential component
of protective innate immunity to C. albicans. Loss of C3 results
in increased susceptibility to infection with this organism (Fig.
1 and 2), which is due to defects in fungal clearance (Fig. 5) but
not defective inflammatory responses. These results therefore
suggest that that the increased inflammation seen in the kid-
neys and blood at 3 days (Fig. 2) is due to higher fungal
burdens and not dysregulation of the inflammatory response.
Indeed, although not truly representative of systemic infection,
using a peritoneal model of candidiasis we could demonstrate
that the inflammatory responses in C3-deficient animals were
equivalent to those observed in wild-type mice (Fig. 3 and 4).
Given that susceptibility due to C5 deficiency results from
aberrant inflammatory responses (19), these results suggest
that C3 is not essentially required for C5 activation. Under
conditions of C3 deficiency, C5 activation is presumably me-
diated through the thrombin pathway (12, 30).
C. glabrata is another species of Candida which has been
increasingly associated with opportunistic infections in immu-
nocompromised individuals, yet relatively little is known about
the host factors which mediate immunity to this organism.
Unlike C. albicans, C. glabrata does not induce a lethal phe-
notype in immunocompetent mice, even at high inoculums (1).
Although this organism can induce the alternative pathway of
complement activation (5), the role of complement in the
control of C. glabrata has not yet been examined. Here we show
that mice deficient in C3 are highly susceptible to systemic
infection with C. glabrata, demonstrating for the first time the
essential role of complement in immunity to this organism.
S. cerevisiae is not normally considered to be a pathogen, but
it has been reported to cause infections under certain settings,
such as immunosuppression (15). In mice, the susceptibility of
C5-deficient animals following i.v. administration with some
clinical isolates has demonstrated the importance of the com-
plement pathway in the control of infection with these micro-
FIG. 4. C3 deficiency does not affect late inflammatory responses to C. albicans. C3/ and wild-type mice were infected i.p. with 1  106 CFU
of C. albicans, and inflammatory responses were measured at day 4. (A) Representative flow cytometric profile showing the gate used (25) to
identify recruited macrophages. C3 deficiency does not affect cellular recruitment (B) or inflammatory cytokine production (C) following i.p.
administration of C. albicans. Values for the wild type versus C3/ are as follows: 1.18  107  1.97  106 versus 6.65  106  1.20  106 total
cells/ml. Values for the wild type are as follows: RANTES, 5.0  0.4 pg/ml; G-CSF, 80  16 pg/ml; KC, 4.1  1.1 pg/ml; granulocyte-macrophage
CSF (GM-CSF), 1.3  0.3 pg/ml; IL-1 (IL-1b), 10.9  3.5 pg/ml; macrophage inhibitory protein 1 (MIP-1a), 29.5  18.0 pg/ml; tumor necrosis
factor (TNF), 115 25 pg/ml; IL-6, 2.1 1.1 pg/ml; monocyte chemoattractant protein 1 (MCP-1), 98 46 pg/ml; IL-1 (IL-1a), 15.7 1.8 pg/ml;
IL-10, 5.3  1.2 pg/ml; and macrophage inhibitory protein 1 (MIP-1b), 2.8  1.0 pg/ml. *, P  0.05 (n 	 6 animals per group per experiment).
The data shown in panel B are pooled from three independent experiments. Bars indicate mean values of the data.
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organisms (4). Here we explored the effect of C3 deficiency
upon administration of very high doses of a standard labora-
tory strain of S. cerevisiae, with the expectation that the lack of
fungal clearance caused by complement deficiency may pro-
mote susceptibility, as we had observed for C. albicans. Sur-
prisingly, we found that administration of high doses of S.
cerevisiae caused the rapid death (within 24 h) of C57BL/6
wild-type mice and that deficiency in C3 and C5 was, in fact,
protective under these conditions (Fig. 7). Inoculation of a
high dose of C. albicans has also been shown to induce rapid
lethality in mice, and in line with our findings using Saccharo-
myces, the loss of complement function was protective in this
model (8). These results therefore suggest that complement
FIG. 5. C3 deficiency delays fungal clearance. C3/ and wild-type mice were infected i.v. with 1  104 CFU of C. albicans, and fungal burdens
in various organs were determined at 24, 48 and 72 h. *, P  0.05 (n 
 6 animals per group). Bars indicate mean values of the data. Values for
24-h wild type versus C3/ are as follows: heart, 234.6  107 versus 212,755  212,165 CFU/g; lung, 262  104 versus 532  175 CFU/g; liver,
137  12 versus 217  68 CFU/g; brain, 217  68 versus 966  367 CFU/g; spleen, 1,505  296 versus 5,834  2,912 CFU/g; kidney, 10,350 
2,998 versus 1.86  105  6.0  104 CFU/g. Values for 48-h wild type versus C3/ are as follows: heart, 100 versus 141  28 CFU/g; lung, 100
versus 309 100 CFU/g; liver, 128 23 versus 222 58 CFU/g; brain, 1,007 907 versus 2,260 1,399 CFU/g; spleen, 593 120 versus 10,000
1,576 CFU/g; kidney, 57,823  26,218 versus 3.8  105  1.2  105 CFU/g. Values for 72-h wild type versus C3/ are as follows: heart, 100
versus 181  81 CFU/g; lung, 100 versus 926  515 CFU/g; liver, 112  12 versus 211  61 CFU/g; brain, 154.3  54 versus 572  192 CFU/g;
spleen, 459  113 versus 1,672  791 CFU/g; and kidney, 9,833  5,412 versus 2.4  105  9.4  104 CFU/g.
FIG. 6. C3 deficiency increases susceptibility to infection with C.
glabrata. C57BL/6 wild-type (F) and C3-deficient (E) mice were in-
fected with 7  107 CFU of C. glabrata i.v. and were monitored for
survival over 21 days, as described in Materials and Methods. The data
shown are pooled from two independent experiments. *, P  0.05.
FIG. 7. C3 and C5 deficiency protects against lethality induced
upon high-dose infection with S. cerevisiae. C57BL/6 wild-type or C3-
deficient, DBA/2, and BALB/c mice were infected with 1  108 CFU
of S. cerevisiae i.v. and were monitored for survival over 21 days, as
described in Materials and Methods. The data shown are pooled from
two independent experiments. *, P  0.05.
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itself acts in a deleterious fashion upon high dose inoculation,
irrespective of the fungal species; however, the mechanisms for
these effects are still unclear. Particularly intriguing is the ap-
parent strain specificity in this response (the effect was far less
marked in BALB/c mice than in C57BL/6 mice).
In conclusion, the use of gene-deficient mice has provided
invaluable insights into the functions of individual components
of many biological processes. We have shown here that C3
plays an essential role in the control of opportunistic fungal
infections, but it may also contribute to mortality under certain
conditions. Although our studies with C. albicans suggest that
the primary function of C3 is in mediating fungal clearance, the
exact role of this complement component in the control of
other fungal pathogens still needs to be explored.
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